Elevated serum resistin in juvenile idiopathic arthritis: Relation to categories and disease activity

Journal of Clinical Immunology

Volumn 33, Issue 1, 2013, Pages 297-301

  Gheita, Tamer A ^a   El Gazzar, Iman I ^a   El Shazly, Reem I ^a   El Din, Abeer M Nour ^b   Abdel Rasheed, Enas ^b   Bassyouni, Rasha H ^c  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c Fayoum University   (Egypt)

Author keywords

Categories; Childhood HAQ; JADAS27; Juvenile idiopathic arthritis; Resistin

Indexed keywords

ANTINUCLEAR ANTIBODY; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; RESISTIN; BIOLOGICAL MARKER; RHEUMATOID FACTOR;

ARTHRITIS; ARTICLE; CHILD; CHILDHOOD HEALTH ASSESSMENT QUESTIONNAIRE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; FATIGUE; FEMALE; FEVER; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; JUVENILE ARTHRITIS DISEASE ACTIVITY SCORE IN 27 JOINT; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RASH; SCHOOL CHILD; SCORING SYSTEM; UVEITIS; ADOLESCENT; BIOSYNTHESIS; BLOOD; CLASSIFICATION; COMPARATIVE STUDY; IMMUNOLOGY; UPREGULATION;

ADOLESCENT; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; CHILD; FEMALE; HUMANS; MALE; RESISTIN; RHEUMATOID FACTOR; UP-REGULATION;

MLCS; MLOWN;

EID: 84876431249     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9760-6     Document Type: Article

References (25)

1. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390-2.
2. Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Schontube M, et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46:2392-401.
3. Karmiris K, Koutroubakis IE. Resistin: another rising biomarker in inflammatory bowel disease? Eur J Gastroenterol Hepatol. 2007; 19(12):1035-7.
4. Derdemezis CS, Voulgari PV, Drosos AA, Kiortsis DN. Obesity, adipose tissue and rheumatoid arthritis: coincidence or more complex relationship? Clin Exp Rheumatol. 2011;29(4):712-27.
5. Gómez R, Conde J, Scotece M, Gómez-Reino JJ, Lago F, Gualillo O. What's new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol. 2011;7(9):528-36.
6. Toussirot E, Streit G, Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem. 2007;14(10):1095-100.
7. Stofkova A. Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocr Regul. 2010;44(1):25-36.
8. Rho YH, Chung CP, Solus JF, Raggi P, Oeser A, Gebretsadik T, et al. Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 2010;62(5):1259-64.
9. Bostrom EA, Svensson M, Andersson S, Jonsson IM, Ekwall AK, Eisler T, et al. Resistin and insulin/insulin-like growth factor signaling in rheumatoid arthritis. Arthritis Rheum. 2011;63(10): 2894-904.
10. Senolt L, Housa D, Vernerová Z, Jirásek T, Svobodová R, Veigl D, et al. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis. 2007;66(4):458-63.
11. Schaffler A, Ehling A, Neumann E, Herfarth H, Tarner I, Scholmerich J, et al. Adipocytokines in synovial fluid. JAMA. 2003;290(13):1709-10.
12. Klein-Wieringa IR, van der Linden MP, Knevel R, Kwekkeboom JC, van Beelen E, Huizinga TW, et al. Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis. Arthritis Rheum. 2011;63(9):2567-74.
13. Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum. 2009;61(5):658-66.
14. Singh G, Athreya BH, Fries JF, Goldsmith DP, et al. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994;37(12):1761-9.
15. Forsblad d'Elia H, Pullerits R, Carlsten H, Bokarewa M. Resistin in serum is associated with higher levels of IL-1Ra in postmenopausal women with rheumatoid arthritis. Rheumatology (Oxford). 2008;47(7):1082-7.
16. Migita K, Maeda Y, Miyashita T, Kimura H, Nakamura M, Ishibashi H, et al. The serum levels of resistin in rheumatoid arthritis patients. Clin Exp Rheumatol. 2006;24(6):698-701.
17. Giles JT, Allison M, Bingham 3rd CO, Scott Jr WM, Bathon JM. Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Rheum. 2009;61(9):1248-56.
18. Gonzalez-Gay MA, Garcia-Unzueta MT, Gonzalez-Juanatey C, Miranda-Filloy JA, Vazquez-Rodriguez TR, De Matias JM, et al. Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2008;26(2):311-6.
19. Yoshino T, Kusunoki N, Tanaka N, Kaneko K, Kusunoki Y, Endo H, et al. Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern Med. 2011;50(4):269-75.
20. Straburzyńska-Lupa A, Nowak A, Pilaczyńska- Szcześniak L Straburzyńska-Migaj E, Romanowski W, Karolkiewicz J, et al. Visfatin, resistin, hsCRP and insulin resistance in relation to abdominal obesity in women with rheumatoid arthritis. Clin Exp Rheumatol. 2010;28(1):19-24.
21. Bostrom EA, Ekstedt M, Kechagias S, Sjowall C, Bokarewa MI, Almer S. Resistin is associated with breach of tolerance and antinuclear antibodies in patients with hepatobiliary inflammation. Scand J Immunol. 2011;74(5):463-70.
22. Lin Y-T, et al. The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev 2011, doi:10.1016/j. autrev.2011.02.001
23. Beukelman T, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Car Res. 2011;63: 465-82.
24. Nozue H, Imai H, Saitoh H, Aoki T, Ichikawa K, Kamoda T. Serum resistin concentrations in children with Kawasaki disease. Inflamm Res. 2010;59(11):915-20.
25. Kemmotsu Y, Saji T, Kusunoki N, Tanaka N, Nishimura C, Ishiguro A, Kawai S. Serum adipokine profiles in Kawasaki disease. Mod Rheumatol. 2012;22(1):66-72.